Parsons Capital Management’s Relmada Therapeutics RLMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.45M	Buy	352,500 +89,500	+34%	+$423K	0.11%	169
2025 Q4	$1.27M	Buy	263,000 +99,664	+61%	+$334K	0.07%	217
2025 Q3	$328K	Hold	163,336	–	–	0.02%	371
2025 Q2	$98.1K	Hold	163,336	–	–	0.01%	436
2025 Q1	$44.1K	Hold	163,336	–	–	﹤0.01%	430
2024 Q4	$84.9K	Sell	163,336 -839,359	-84%	-$2.05M	﹤0.01%	435
2024 Q3	$3.25M	Buy	1,002,695 +26,750	+3%	+$86.6K	0.21%	112
2024 Q2	$2.93M	Buy	975,945 +2,425	+0.2%	+$8.77K	0.2%	114
2024 Q1	$4.53M	Buy	973,520 +23,679	+2%	+$114K	0.31%	77
2023 Q4	$3.93M	Sell	949,841 -24,241	-2%	-$71.8K	0.28%	85
2023 Q3	$2.92M	Buy	974,082 +100,770	+12%	+$299K	0.23%	93
2023 Q2	$2.15M	Buy	873,312 +151,146	+21%	+$418K	0.16%	127
2023 Q1	$1.63M	Buy	722,166 +225,912	+46%	+$779K	0.13%	158
2022 Q4	$1.73M	Sell	496,254 -7,547	-1%	-$66.3K	0.14%	143
2022 Q3	$18.7M	Buy	503,801 +25	+0%	+$693	1.67%	9
2022 Q2	$9.57M	Buy	503,776 +700	+0.1%	+$15.3K	0.86%	21
2022 Q1	$13.6M	Sell	503,076 -336	-0.1%	-$6.95K	1.03%	17
2021 Q4	$11.3M	Buy	503,412 +30,438	+6%	+$677K	0.81%	22
2021 Q3	$12.4M	Buy	472,974 +22,562	+5%	+$604K	0.97%	18
2021 Q2	$14.4M	Sell	450,412 -1,000	-0.2%	-$34.7K	1.1%	12
2021 Q1	$15.9M	Sell	451,412 -200	-0%	-$7K	1.3%	10
2020 Q4	$14.5M	Sell	451,612 -3,525	-0.8%	-$121K	1.25%	11
2020 Q3	$17.1M	Buy	455,137 +1,050	+0.2%	+$40.6K	1.67%	7
2020 Q2	$20.3M	Buy	454,087 +28,512	+7%	+$1.21M	2.16%	6
2020 Q1	$14.5M	Buy	425,575 +58,642	+16%	+$2.36M	1.87%	7
2019 Q4	$14.3M	Buy	+366,933	New	+$11.1M	1.44%	11